Safety of SGLT2 Inhibitors and Urinary Tract Infections in Clinical Practice—A Cross-Sectional Study

Safety of SGLT2 Inhibitors and Urinary Tract Infections in Clinical Practice—A Cross-Sectional Study

<i>Background and Objectives</i>: Type 2 diabetes (T2DM) affects millions across the globe, generating a veritable public health issue through quality-of-life-reducing chronic complications, among which urinary tract infections are the most common. A shift in the disease managing paradig...

Full description

Saved in:
Bibliographic Details
Main Authors: Liana Iordan, Vlad Florian Avram, Bogdan Timar, Adrian Sturza, Simona Popescu, Oana Albai, Romulus Zorin Timar
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Medicina
Subjects:
type 2 diabetes mellitus
diabetes medications
SGLT2 inhibitors
urinary tract infection
risk factors
Online Access:https://www.mdpi.com/1648-9144/60/12/1974
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/60/12/1974

Similar Items